| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Aisling S Carr, Chris R Cardwell, Peter O McCarron, John McConvill. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC neurology. vol 10. 2010-10-19. PMID:20565885. |
the aim was to collate all myasthenia gravis (mg) epidemiological studies including achr mg and musk mg specific studies. |
2010-10-19 |
2023-08-12 |
Not clear |
| Erik H Niks, Jan B M Kuks, John H J Wokke, Henk Veldman, Egbert Bakker, Jan J G M Verschuuren, Jaap J Plom. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia. Muscle & nerve. vol 42. issue 2. 2010-08-17. PMID:20544919. |
autoantibodies to muscle-specific kinase (musk) can cause myasthenia gravis (mg). |
2010-08-17 |
2023-08-12 |
Not clear |
| Marija Zagar, Davorka Vranjes, Marija Sostarko, Zeljka Vogrinc, Ervina Bilić, Milica Trbojević Cep. Myasthenia gravis patients with anti-MuSK antibodies. Collegium antropologicum. vol 33. issue 4. 2010-03-18. PMID:20102061. |
in myasthenia gravis (mg) patients without detectable anti-acetylcholine receptor (anti-achr) antibody, referred to as seronegative myasthenia gravis patients, there is a variable proportion of patients with antibodies against the muscle-specific kinase (musk). |
2010-03-18 |
2023-08-12 |
Not clear |
| b' Trinidad Blanco Hern\\xc3\\xa1ndez, A Navarr\\xc3\\xa9 A, A Brocalero, A Cervell\\xc3\\xb. [Seronegative myasthenia gravis associated with other autoimmune diseases]. Neurologia (Barcelona, Spain). vol 24. issue 6. 2010-02-25. PMID:19798609.' |
the presence of muscle-specific receptor tyrosine kinase (musk) defines a subset of patients with generalized myasthenia gravis. |
2010-02-25 |
2023-08-12 |
Not clear |
| Tetsuro Konishi, Masayuki Kousaka, Kentarou Yamakawa, Masaru Matsui, Kiyoe Oht. [Effects of acetylcholinesterase inhibitors on patients with MuSK antibody positive myasthenia gravis]. Rinsho shinkeigaku = Clinical neurology. vol 49. issue 10. 2010-01-19. PMID:19999149. |
[effects of acetylcholinesterase inhibitors on patients with musk antibody positive myasthenia gravis]. |
2010-01-19 |
2023-08-12 |
Not clear |
| Tetsuro Konishi, Masayuki Kousaka, Kentarou Yamakawa, Masaru Matsui, Kiyoe Oht. [Effects of acetylcholinesterase inhibitors on patients with MuSK antibody positive myasthenia gravis]. Rinsho shinkeigaku = Clinical neurology. vol 49. issue 10. 2010-01-19. PMID:19999149. |
in order to clarify the clinical characteristics and effects of acetylcholinesterase inhibitors of patients with generalized myasthenia gravis with antibodies to muscle specific kinase (musk), we investigated seven patients with musk antibodies and eleven patients without both antibodies of acetylcholine receptor and musk. |
2010-01-19 |
2023-08-12 |
Not clear |
| W Pascale ter Beek, Pilar Martínez-Martínez, Mario Losen, Marc H de Baets, Axel R Wintzen, Jan J G M Verschuuren, Erik H Niks, Sjoerd G van Duinen, Angela Vincent, Peter C Molenaa. The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates. The American journal of pathology. vol 175. issue 4. 2009-12-09. PMID:19745065. |
in 5 to 7% of myasthenia gravis (mg) cases, the patients' blood contains antibodies to musk. |
2009-12-09 |
2023-08-12 |
Not clear |
| Edward Littleton, Mathias Dreger, Jackie Palace, Angela Vincen. Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies. Molecular & cellular proteomics : MCP. vol 8. issue 7. 2009-12-01. PMID:19332416. |
as a model system we used a muscle cell line, te671, that endogenously expresses muscle-specific tyrosine receptor kinase (musk) and sera or plasmas from patients with a subtype of the autoimmune disease myasthenia gravis in which patients have autoantibodies against musk. |
2009-12-01 |
2023-08-12 |
human |
| Anna Rostedt Punga, Erik Stålber. Acetylcholinesterase inhibitors in MG: to be or not to be? Muscle & nerve. vol 39. issue 6. 2009-08-05. PMID:19260048. |
myasthenia gravis (mg) is an autoimmune disorder usually caused by antibodies against either the acetylcholine receptor (achr) or muscle-specific tyrosine kinase (musk) at the neuromuscular junction. |
2009-08-05 |
2023-08-12 |
Not clear |
| S Martignago, M Fanin, E Albertini, E Pegoraro, C Angelin. Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR. Neuropathology and applied neurobiology. vol 35. issue 1. 2009-03-09. PMID:19187062. |
muscle histopathology in myasthenia gravis with antibodies against musk and achr. |
2009-03-09 |
2023-08-12 |
Not clear |
| S Martignago, M Fanin, E Albertini, E Pegoraro, C Angelin. Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR. Neuropathology and applied neurobiology. vol 35. issue 1. 2009-03-09. PMID:19187062. |
we compared myopathological features in myasthenia gravis (mg) patients with antibodies against achr (seropositive) and muscle-specific tyrosin-kinase (musk). |
2009-03-09 |
2023-08-12 |
Not clear |
| Yung-Chuan Huang, Jiann-Horng Yeh, Hou-Chang Chiu, Wei-Hung Che. Clinical characteristics of MuSK antibody-positive myasthenia gravis in Taiwan. Journal of the Formosan Medical Association = Taiwan yi zhi. vol 107. issue 7. 2008-11-14. PMID:18632417. |
clinical characteristics of musk antibody-positive myasthenia gravis in taiwan. |
2008-11-14 |
2023-08-12 |
Not clear |
| Lorenzo Maggi, Francesca Andreetta, Carlo Antozzi, Paolo Confalonieri, Ferdinando Cornelio, Vidmer Scaioli, Renato Mantegazz. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor. Neuromuscular disorders : NMD. vol 18. issue 8. 2008-10-23. PMID:18657424. |
even though a single case of thymoma-associated myasthenia gravis with anti-muscle specific kinase (musk) antibodies has been reported, to our knowledge, seronegative thymoma-associated myasthenia gravis has not been described. |
2008-10-23 |
2023-08-12 |
Not clear |
| Lorenzo Maggi, Francesca Andreetta, Carlo Antozzi, Paolo Confalonieri, Ferdinando Cornelio, Vidmer Scaioli, Renato Mantegazz. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor. Neuromuscular disorders : NMD. vol 18. issue 8. 2008-10-23. PMID:18657424. |
we report on two cases of this disease without antibodies to achr or musk as a further evidence of the variability of myasthenia gravis in terms of antibody profile and thymic pathological findings. |
2008-10-23 |
2023-08-12 |
Not clear |
| Maria Isabel Leite, Saiju Jacob, Stuart Viegas, Judy Cossins, Linda Clover, B Paul Morgan, David Beeson, Nick Willcox, Angela Vincen. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain : a journal of neurology. vol 131. issue Pt 7. 2008-10-22. PMID:18515870. |
antibodies to muscle specific kinase [musk; musk antibody positive myasthenia gravis (musk-mg)] make up a variable proportion of the remaining 20%. |
2008-10-22 |
2023-08-12 |
human |
| Nazem Atassi, Anthony A Amat. Muscle-specific kinase (MuSK) antibody-associated myasthenia gravis after bone marrow transplantation. Muscle & nerve. vol 38. issue 2. 2008-09-29. PMID:18537145. |
muscle-specific kinase (musk) antibody-associated myasthenia gravis after bone marrow transplantation. |
2008-09-29 |
2023-08-12 |
Not clear |
| Kazuhiro Shigemoto, Sachiho Kubo, Chen Jie, Naohito Hato, Yasuhito Abe, Norifumi Ueda, Naoto Kobayashi, Kenji Kameda, Katsumi Mominoki, Atsuo Miyazawa, Akihito Ishigami, Seiji Matsuda, Naoki Maruyam. Myasthenia gravis experimentally induced with muscle-specific kinase. Annals of the New York Academy of Sciences. vol 1132. 2008-09-08. PMID:18096854. |
notably, autoantibodies against musk were found in a proportion of patients with generalized myasthenia gravis (mg) but without the characteristic achr autoantibodies. |
2008-09-08 |
2023-08-12 |
Not clear |
| Amelia Evoli, Maria R Bianchi, Raffaella Riso, Giacomo M Minicuci, Anna P Batocchi, Serenella Servidei, Flavia Scuderi, Emanuela Bartoccion. Response to therapy in myasthenia gravis with anti-MuSK antibodies. Annals of the New York Academy of Sciences. vol 1132. 2008-09-08. PMID:18567856. |
myasthenia gravis (mg) with antibodies against the muscle-specific tyrosine kinase (musk abs) is often a severe disease requiring aggressive treatment. |
2008-09-08 |
2023-08-12 |
Not clear |
| Angela Vincent, Maria Isabel Leite, Maria Elena Farrugia, Saiju Jacob, Stuart Viegas, Hiro Shiraishi, Olivier Benveniste, B Paul Morgan, David Hilton-Jones, John Newsom-Davis, David Beeson, Nick Willco. Myasthenia gravis seronegative for acetylcholine receptor antibodies. Annals of the New York Academy of Sciences. vol 1132. 2008-09-08. PMID:18567857. |
patients without either achr or musk antibodies (seronegative myasthenia) appear to present another disease subtype that is highly similar to that of typical myasthenia gravis. |
2008-09-08 |
2023-08-12 |
Not clear |
| K Shigemot. Myasthenia gravis induced by autoantibodies against MuSK. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology. vol 26. issue 3. 2008-08-26. PMID:18646570. |
myasthenia gravis induced by autoantibodies against musk. |
2008-08-26 |
2023-08-12 |
Not clear |